Anna-Katharina Meissner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna-Katharina Meissner has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Ruess
University of Cologne
22 shared publications - David Reinecke
Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
22 shared publications - Maximilian Ingolf Ruge
Department of Neurosurgery, University of Cologne , Cologne
22 shared publications - Niklas von Spreckelsen
Department of General Neurosurgery, Centre of Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, Kerpener Str. 62, 50937 Köln, Germany
22 shared publications - Reinhard Büttner
Center for Integrated Oncology Aachen Köln Bonn Düsseldorf, Germany
22 shared publications - Volker Neuschmelting
Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
22 shared publications
Latest Publications
- Open Access
- 7 March 2025
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 35 (3) , 521-532
Evaluation of CT and MRI Radiomics for an Early Assessment of Diffuse Axonal Injury in Patients with Traumatic Brain Injury Compared to Conventional Radiological Diagnosis
Background: De- and acceleration traumata can cause diffuse axonal injury (DAI) in patients with traumatic brain injury (TBI). The diagnosis of DAI on CT is challenging due to the lack of structural abnormalities. Radiomics, a method from the field of artificial intelligence (AI) offers the opportunity to extract additional information from imaging data. The purpose of this work was the evaluation of the feasibility of radiomics for an improved diagnosis of DAI in comparison to conventional radiological image assessment. Methods: CT and MR imaging was performed in 42 patients suspicious of DAI due to the clinical state, and two control groups (n = 44;42). DAI was diagnosed by experienced neuroradiologists. Radiomics features were extracted using a standardized MRI-based atlas of the predilection areas for DAI. Different MRI and CT based models were trained and validated by five-fold cross validation. Diagnostic performance was compared to the reading of two experienced radiologists and further validated in an external test dataset. Results: The MRI and CT models showed significant differences in radiomics features between patients with DAI and controls. The developed MRI based random forest classifier yielded an accuracy of 80–90%. The best performing CT model yielded an accuracy of 88% in the training data and 70% in the external test data. The results were comparable to conventional image analysis which achieved an accuracy of 70–81% for CT-based diagnosis. Conclusion: MRI- and CT-based radiomics analysis is feasible for the assessment of DAI. The radiomics classifier achieved equivalent performance rates as visual radiological image diagnosis. Especially a radiomics based CT classifier can be of clinical value as a screening and AI-based decision support tool for patients with TBI.
- 7 March 2025
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 35 (3) , 521-532
Open AccessEvaluation of CT and MRI Radiomics for an Early Assessment of Diffuse Axonal Injury in Patients with Traumatic Brain Injury Compared to Conventional Radiological Diagnosis
Background: De- and acceleration traumata can cause diffuse axonal injury (DAI) in patients with traumatic brain injury (TBI). The diagnosis of DAI on CT is challenging due to the lack of structural abnormalities. Radiomics, a method from the field of artificial intelligence (AI) offers the opportunity to extract additional information from imaging data. The purpose of this work was the evaluation of the feasibility of radiomics for an improved diagnosis of DAI in comparison to conventional radiological image assessment. Methods: CT and MR imaging was performed in 42 patients suspicious of DAI due to the clinical state, and two control groups (n = 44;42). DAI was diagnosed by experienced neuroradiologists. Radiomics features were extracted using a standardized MRI-based atlas of the predilection areas for DAI. Different MRI and CT based models were trained and validated by five-fold cross validation. Diagnostic performance was compared to the reading of two experienced radiologists and further validated in an external test dataset. Results: The MRI and CT models showed significant differences in radiomics features between patients with DAI and controls. The developed MRI based random forest classifier yielded an accuracy of 80–90%. The best performing CT model yielded an accuracy of 88% in the training data and 70% in the external test data. The results were comparable to conventional image analysis which achieved an accuracy of 70–81% for CT-based diagnosis. Conclusion: MRI- and CT-based radiomics analysis is feasible for the assessment of DAI. The radiomics classifier achieved equivalent performance rates as visual radiological image diagnosis. Especially a radiomics based CT classifier can be of clinical value as a screening and AI-based decision support tool for patients with TBI.
- Open Access
- 30 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (23) , 2701
Image Quality Assessment and Reliability Analysis of Artificial Intelligence-Based Tumor Classification of Stimulated Raman Histology of Tumor Biobank Samples
Background: Stimulated Raman histology (SRH) is a label-free optical imaging method for rapid intraoperative analysis of fresh tissue samples. Analysis of SRH images using Convolutional Neural Networks (CNN) has shown promising results for predicting the main histopathological classes of neurooncological tumors. Due to the relatively low number of rare tumor representations in CNN training datasets, a valid prediction of rarer entities remains limited. To develop new reliable analysis tools, larger datasets and greater tumor variety are crucial. One way to accomplish this is through research biobanks storing frozen tumor tissue samples. However, there is currently no data available regarding the pertinency of previously frozen tissue samples for SRH analysis. The aim of this study was to assess image quality and perform a comparative reliability analysis of artificial intelligence-based tumor classification using SRH in fresh and frozen tissue samples. Methods: In a monocentric prospective study, tissue samples from 25 patients undergoing brain tumor resection were obtained. SRH was acquired in fresh and defrosted samples of the same specimen after varying storage durations at −80 °C. Image quality was rated by an experienced neuropathologist, and prediction of histopathological diagnosis was performed using two established CNNs. Results: The image quality of SRH in fresh and defrosted tissue samples was high, with a mean image quality score of 1.96 (range 1–5) for both groups. CNN analysis showed high internal consistency for histo-(Cα 0.95) and molecular (Cα 0.83) pathological tumor classification. The results were confirmed using a dataset with samples from the local tumor biobank (Cα 0.91 and 0.53). Conclusions: Our results showed that SRH appears comparably reliable in fresh and frozen tissue samples, enabling the integration of tumor biobank specimens to potentially improve the diagnostic range and reliability of CNN prediction tools.
- 30 November 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (23) , 2701
Open AccessImage Quality Assessment and Reliability Analysis of Artificial Intelligence-Based Tumor Classification of Stimulated Raman Histology of Tumor Biobank Samples
Background: Stimulated Raman histology (SRH) is a label-free optical imaging method for rapid intraoperative analysis of fresh tissue samples. Analysis of SRH images using Convolutional Neural Networks (CNN) has shown promising results for predicting the main histopathological classes of neurooncological tumors. Due to the relatively low number of rare tumor representations in CNN training datasets, a valid prediction of rarer entities remains limited. To develop new reliable analysis tools, larger datasets and greater tumor variety are crucial. One way to accomplish this is through research biobanks storing frozen tumor tissue samples. However, there is currently no data available regarding the pertinency of previously frozen tissue samples for SRH analysis. The aim of this study was to assess image quality and perform a comparative reliability analysis of artificial intelligence-based tumor classification using SRH in fresh and frozen tissue samples. Methods: In a monocentric prospective study, tissue samples from 25 patients undergoing brain tumor resection were obtained. SRH was acquired in fresh and defrosted samples of the same specimen after varying storage durations at −80 °C. Image quality was rated by an experienced neuropathologist, and prediction of histopathological diagnosis was performed using two established CNNs. Results: The image quality of SRH in fresh and defrosted tissue samples was high, with a mean image quality score of 1.96 (range 1–5) for both groups. CNN analysis showed high internal consistency for histo-(Cα 0.95) and molecular (Cα 0.83) pathological tumor classification. The results were confirmed using a dataset with samples from the local tumor biobank (Cα 0.91 and 0.53). Conclusions: Our results showed that SRH appears comparably reliable in fresh and frozen tissue samples, enabling the integration of tumor biobank specimens to potentially improve the diagnostic range and reliability of CNN prediction tools.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Figure S2. Illustration of two SRH images with different signal-to-noise ratios due to ambient temperature and autofocus variability.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Figure S2. Illustration of two SRH images with different signal-to-noise ratios due to ambient temperature and autofocus variability.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Data from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Purpose:Recent artificial intelligence algorithms aided intraoperative decision-making via stimulated Raman histology (SRH) during craniotomy. This study assesses deep learning algorithms for rapid intraoperative diagnosis from SRH images in small stereotactic-guided brain biopsies. It defines a minimum tissue sample size threshold to ensure diagnostic accuracy.Experimental Design:A prospective single-center study examined 121 SRH images from 84 patients with unclear intracranial lesions undergoing stereotactic brain biopsy. Unprocessed, label-free samples were imaged using a portable fiber laser Raman scattering microscope. Three deep learning models were tested to (i) identify tumorous/nontumorous tissue as qualitative biopsy control; (ii) subclassify into high-grade glioma (central nervous system World Health Organization grade 4), diffuse low-grade glioma (central nervous system World Health Organization grades 2–3), metastases, lymphoma, or gliosis; and (iii) molecularly subtype IDH and 1p/19q statuses of adult-type diffuse gliomas. Model predictions were evaluated against frozen section analysis and final neuropathologic diagnoses.Results:The first model identified tumorous/nontumorous tissue with 91.7% accuracy. Sample size on slides impacted accuracy in brain tumor subclassification (81.6%, κ = 0.72 frozen section; 73.9%, κ = 0.61 second model), with SRH images being smaller than hematoxylin and eosin images (4.1 ± 2.5 mm2 vs. 16.7 ± 8.2 mm2, P < 0.001). SRH images with more than 140 high-quality patches and a mean squeezed sample of 5.26 mm2 yielded 89.5% accuracy in subclassification and 93.9% in molecular subtyping of adult-type diffuse gliomas.Conclusions:Artificial intelligence–based SRH image analysis is non-inferior to frozen section analysis in detecting and subclassifying brain tumors during small stereotactic-guided biopsies once a critical squeezed sample size is reached. Beyond frozen section analysis, it enables valid molecular glioma subtyping, allowing faster treatment decisions in the future; however, refinement is needed for long-term application.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Purpose:Recent artificial intelligence algorithms aided intraoperative decision-making via stimulated Raman histology (SRH) during craniotomy. This study assesses deep learning algorithms for rapid intraoperative diagnosis from SRH images in small stereotactic-guided brain biopsies. It defines a minimum tissue sample size threshold to ensure diagnostic accuracy.Experimental Design:A prospective single-center study examined 121 SRH images from 84 patients with unclear intracranial lesions undergoing stereotactic brain biopsy. Unprocessed, label-free samples were imaged using a portable fiber laser Raman scattering microscope. Three deep learning models were tested to (i) identify tumorous/nontumorous tissue as qualitative biopsy control; (ii) subclassify into high-grade glioma (central nervous system World Health Organization grade 4), diffuse low-grade glioma (central nervous system World Health Organization grades 2–3), metastases, lymphoma, or gliosis; and (iii) molecularly subtype IDH and 1p/19q statuses of adult-type diffuse gliomas. Model predictions were evaluated against frozen section analysis and final neuropathologic diagnoses.Results:The first model identified tumorous/nontumorous tissue with 91.7% accuracy. Sample size on slides impacted accuracy in brain tumor subclassification (81.6%, κ = 0.72 frozen section; 73.9%, κ = 0.61 second model), with SRH images being smaller than hematoxylin and eosin images (4.1 ± 2.5 mm2 vs. 16.7 ± 8.2 mm2, P < 0.001). SRH images with more than 140 high-quality patches and a mean squeezed sample of 5.26 mm2 yielded 89.5% accuracy in subclassification and 93.9% in molecular subtyping of adult-type diffuse gliomas.Conclusions:Artificial intelligence–based SRH image analysis is non-inferior to frozen section analysis in detecting and subclassifying brain tumors during small stereotactic-guided biopsies once a critical squeezed sample size is reached. Beyond frozen section analysis, it enables valid molecular glioma subtyping, allowing faster treatment decisions in the future; however, refinement is needed for long-term application.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S6. The second model was used to predict the class of each acquired entity from small biopsy tissue samples. These predictions were compared to the frozen section diagnosis after tumor radiotherapy. The level of accuracy depended on the final diagnosis and the predefined model label assignment to the respective subclasses.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S6. The second model was used to predict the class of each acquired entity from small biopsy tissue samples. These predictions were compared to the frozen section diagnosis after tumor radiotherapy. The level of accuracy depended on the final diagnosis and the predefined model label assignment to the respective subclasses.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S2. The first model illustrates each collected entity with corresponding class predictions (CP). It classifies small biopsy tissue samples as tumorous or non-tumorous tissue; accuracy depends on the final diagnosis (FD).
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S2. The first model illustrates each collected entity with corresponding class predictions (CP). It classifies small biopsy tissue samples as tumorous or non-tumorous tissue; accuracy depends on the final diagnosis (FD).
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S6. The second model was used to predict the class of each acquired entity from small biopsy tissue samples. These predictions were compared to the frozen section diagnosis after tumor radiotherapy. The level of accuracy depended on the final diagnosis and the predefined model label assignment to the respective subclasses.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S6. The second model was used to predict the class of each acquired entity from small biopsy tissue samples. These predictions were compared to the frozen section diagnosis after tumor radiotherapy. The level of accuracy depended on the final diagnosis and the predefined model label assignment to the respective subclasses.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S7. Illustration of each deep-learning model’s best prediction performance on SRH images with ≥130 high-quality patches (first model) and >140 high-quality patches (second and third model) after stepwise metric performance evaluation. The second model was used to predict the class of each acquired entity from small biopsy tissue samples. The level of accuracy depended on the final integrated diagnosis and the predefined model label assignment to the respective subclasses.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S7. Illustration of each deep-learning model’s best prediction performance on SRH images with ≥130 high-quality patches (first model) and >140 high-quality patches (second and third model) after stepwise metric performance evaluation. The second model was used to predict the class of each acquired entity from small biopsy tissue samples. The level of accuracy depended on the final integrated diagnosis and the predefined model label assignment to the respective subclasses.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S1. Description of the SRH-based diagnostic accuracy of the first model in case of neuropathological diagnosed non-tumorous tissue from open resection procedures since the stereotactic-guided biopsy dataset contained only a few cases due to IRB protocol restrictions and the common non-invasive diagnostic differentiation by means of 18F-FET-PET CT/MRI to distinguish between tumorous and non-tumorous tissue, e.g., in recurrent tumor cases. Non-tumorous tissue samples of the brain summarized here were obtained non- or purposely from surrounding white or gray matter adjacent to the tumor during open tumor en bloc resections. After resection, these tissue parts were extracted from the whole tissue sample for further analysis. Further cases comprised space-occupying suspected tumorous lesions or post-radiotherapy lesions (e.g., pseudoprogression or radiogenic necrosis) due to immense edematous effect. The final FFPE-based diagnosis revealed non-tumorous tissue.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Table S1. Description of the SRH-based diagnostic accuracy of the first model in case of neuropathological diagnosed non-tumorous tissue from open resection procedures since the stereotactic-guided biopsy dataset contained only a few cases due to IRB protocol restrictions and the common non-invasive diagnostic differentiation by means of 18F-FET-PET CT/MRI to distinguish between tumorous and non-tumorous tissue, e.g., in recurrent tumor cases. Non-tumorous tissue samples of the brain summarized here were obtained non- or purposely from surrounding white or gray matter adjacent to the tumor during open tumor en bloc resections. After resection, these tissue parts were extracted from the whole tissue sample for further analysis. Further cases comprised space-occupying suspected tumorous lesions or post-radiotherapy lesions (e.g., pseudoprogression or radiogenic necrosis) due to immense edematous effect. The final FFPE-based diagnosis revealed non-tumorous tissue.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Figure S1. Illustration of unprocessed sample processing and corresponding field of view (FOV) size selection.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning
Supplementary Figure S1. Illustration of unprocessed sample processing and corresponding field of view (FOV) size selection.